MRL-Ipr/lpr mice develop a severe autoimmune disease that resembles systemic lupus erythematosis in humans . The predominant immunological feature in these mice is the development of peripheral lymphadenopathy due to the expansion of an unusual T cell subset (TCR ct//3+5CD3+4 -8-B220+), which may be related to the onset of their autoimmunity. However, it is unknown whether such abnormal lymphocytes proliferate in the specific organs or not . We demonstrated in the present study that the number of liver nonparenchymal mononuclear cells (MNC) in the diseased MRL-Ipr/Ipr mice was 10 times greater than that ofcontrol MRL-+/+ mice. Moreover, the freshlyisolated liver MNC of MRL-Ipr/lpr mice vigorously proliferated in vitro and consisted of abnormal CD3+4-8-lymphocytes. Such in vitro proliferation was not observed in the MNC of other peripheral lymphoid organs . A potent natural cytotoxicity was also confined to the liver MNC in MRL-1pr/1pr mice. In vivo injection of [3H]TdR demonstrated that liver MNC incorporated [3H]TdR; such incorporation showed a peak on day 1, and the MNC-incorporated [3H]TdR appeared in the lymph nodes as late as day 5 after the injection . These results suggest that the liver is a possible site for the proliferation of abnormal lymphocytes, which may migrate thereafter into the peripheral organs in MRL-Ipr/lpr mice.
MRL-Ipr/lpr mice develop a severe autoimmune disease that resembles systemic lupus erythematosis in humans . The predominant immunological feature in these mice is the development of peripheral lymphadenopathy due to the expansion of an unusual T cell subset (TCR ct//3+5CD3+4 -8-B220+), which may be related to the onset of their autoimmunity. However, it is unknown whether such abnormal lymphocytes proliferate in the specific organs or not . We demonstrated in the present study that the number of liver nonparenchymal mononuclear cells (MNC) in the diseased MRL-Ipr/Ipr mice was 10 times greater than that ofcontrol MRL-+/+ mice. Moreover, the freshlyisolated liver MNC of MRL-Ipr/lpr mice vigorously proliferated in vitro and consisted of abnormal CD3+4-8-lymphocytes. Such in vitro proliferation was not observed in the MNC of other peripheral lymphoid organs . A potent natural cytotoxicity was also confined to the liver MNC in MRL-1pr/1pr mice. In vivo injection of [3H]TdR demonstrated that liver MNC incorporated [3H]TdR; such incorporation showed a peak on day 1, and the MNC-incorporated [3H]TdR appeared in the lymph nodes as late as day 5 after the injection . These results suggest that the liver is a possible site for the proliferation of abnormal lymphocytes, which may migrate thereafter into the peripheral organs in MRL-Ipr/lpr mice.
MRL-Ipr/lpr (MRL/Ipr) , mice develop a severe autoimmune disease that resembles SLE and rheumatoid arthritis in humans (1, 2) . The predominant immunological abnormality in these mice is the development of peripheral lymphadenopathy due to the expansion of an unusual T cell subset (TCR-ot/R+ CD3+4 -8 -B220+) . It is well known that MRL-+/+ (MRL/+) mice also develop autoimmunity when they become old (>40 wk) . If lpr/lpr genes are inserted into these mice (i.e., MRL/lpr), development of severe autoimmune disease in their youth (14 wk) is accelerated, accompanied by prominent lymphadenopathy. It is, therefore, postulated that the abnormal double-negative (DN; CD4 -8 -) lymphocytes constituting the lymphadenopathy may be responsible for the development of autoimmunity (e.g., helper function of autoantibody production for B lymphocytes and cytotoxicity against autoantigens) (3) (4) (5) (6) (7) . Despite enormous accumulation of abnormal lymphocytes in the lymph nodes and spleen, the cells do not actively proliferate in these organs (8) . As there is also no evidence of increased proliferation of such lymphocytes in the thymus and bone marrow, it raises the possibility that this lymphadenopathy is caused by mere accumulation of such cells in the periph-'Abbreviations used in this paper. DN, double negative; MNC, mononuclear cells ; MRL/Ipr, MRL-1pr/Ipr; MRL/+, MRL-+/+ . 7 eral organs (9, 10) . However, we reveal here that such abnormal lymphocytes proliferate in the liver ofMRL/lpr mice. Although it is well established that the liver is the major hematopoietic organ in the fetal stage (11) , the present results show that the liver is still an important organ for the production of certain lymphocytes after birth.
Materials and Methods
Mice . Female MRL/Ipr and MRL/+ mice, 5-35 wk of age, were purchased from Charles River Japan, Inc., Japan, and fed under pathogen-free conditions. Cell Preparation . Perfusion was performed to eliminate blood contained in the liver by gentle injection of 10 ml ofPBS (0.01 M, pH 7 .2) into the portal vein just before removal of the liver (12) . To obtain mononuclear cells (MNC), the liver was removed, cut into small pieces by scissors, pressed through 100-gauge stainless steel mesh, and suspended in serum-free RPMI 1640 medium supplemented with antibiotics. This suspension was centrifuged at 250 g for 5 min at 4°C, and the supernatant was removed . The cell pellet was resuspended in an adequate amount (N20 ml/liver) ofthe medium, and nonparenchymal MNC were isolated by FicollIsopaque density (1.090) gradient centrifugation . In the MNC preparation method applied here, the proportion of contaminating phagocytes (i.e., Kupffer cells) was negligible (<4%), as shown previously (12) . MNC in other lymphoid organs, including the lung and the intestine, were collected by the Ficoll-Isopaque method, after which such organs were cut into small pieces with scissors and forced through 200-gauge stainless steel mesh (12) . Bone marrow cells were obtained from the femur to flush out the marrow in conjunction with the Ficoll-Isopaque method (12) . Peripheral blood was collected in a heparinized syringe, and MNC were purified by the Ficoll-Isopaque method .
DNA Synthesis Assay. For determination of spontaneous proliferation, 5 x 101 freshly isolated MNC in 200 p.l RPMI medium supplemented with 1% normal mouse serum and 5 x 10-s M 2-ME were cultured with 0.5 1ACi of [3H]TdR (Amersham International, Amersham, England) for 12 h in a 96-well flat-bottomed microculture plate (Falcon Labware, Oxnard, CA) at 37°C in a 5% COz incubator (12) .
Immunofluorescence Test. Surface phenotype ofcells was identified by using mAbs in conjunction with two-color immunofluorescence tests. The monoclonal reagents used here were fluorescein-or phycoerythrin-conjugated anti-mouse CD3, CD4 (L3T4), CD8 (Lyt-2), B220, and Va8 of TCR (F23.1) antibodies (12) . The fluorescence-positive cells were analyzed by FACScan (Becton Dickinson & Co., Mountain View, CA).
Cytotoxicity Assay. Cytotoxicity was examined by a specific "Cr-release assay of 4-h incubation analysis (12) . Target cells used in this study included a murine lymphoid tumor cell line, YAC-1. The E/T ratios examined were 50:1, 25:1, and 12.5 :1.
In 
Results
Increase in Number and Spontaneous Proliferation ofLiver MNC in MRL/Ipr Mice. We previously established a method for isolating liver MNC after perfusion with PBS in conjunction with Ficoll-Isopaque gradient centrifugation (12) . This method was applied to the isolation ofliver MNC in MRL/Ipr and MRL/+ mice (Table 1) . In MRL/Ipr mice, the onset of disease was at the age of -14 wk. The MRL/lpr and (18,314 ± 8,527 ) was 10 times greater than that (2,666 ± 1,088) in MRL/+ mice. The activity of cell proliferation in liver MNC of MRL/Ipr mice was estimated to be -100 times greater than that of control MRL/+ mice. The cell proliferation assay was then analyzed in liver MNC of MRL/lpr mice of various ages to investigate whether the above result was related to the diseased state in these mice (Fig. 1) . MNC of the lymph nodes were examined in parallel. The increased spontaneous proliferation of MNC in the liver, but not the lymph nodes, was clearly related to the age of the onset of autoimmunity (Fig. 1 A) . Prominent proliferation remained at a high level during the active stage of their disease, although it declined gradually as a function of age. Proliferation of MNC in the lymph nodes was not observed during the entire period . The cell proliferation assay was performed in various lymphoid organs of MRL/Ipr and MRL/+ mice aged 15 wk (Fig. 1 B) . It was demonstrated that the increased proliferation of MNC was confined to the liver among the peripheral lymphoid organs in MRL/Ipr mice. MNC of the bone marrow, that is the hematopoietic organ, greatly proliferated in both MRL/Ipr and MRL/+ mice. Phenotypic Characterization of the Lymphocytes. The surface phenotype of MNC was analyzed by two-color immunofluorescence tests in various lymphoid organs ofMRL/Ipr and MRL/+ mice (Fig. 2) . Here, MNC was simultaneously stained with fluorescein-conjugated anti-CD3 antibody and phycoerythrin-conjugated anti-CD4 and anti-CD8 antibodies to identify the CD3 +4 -8 -cells and CD3+4+ (or 8+) cells. As shown previously (3, 4) and in this study, almost all of the abnormal CD3 +4-8 -DN lymphocytes coexpressed the B220 antigens. Thus, if phycoerythrin-conjugated B220 antibody was added to the above staining schedule, all of the green single-color-positive cells disappeared (data not shown) .
Exp . As shown in Fig. 2 A, abnormal CD3*4 -8 -B220* DN lymphocytes were detected in all peripheral lymphoid organs, including the liver, of MRL/lpr mice. Such abnormal lymphocytes were extremely rare in the thymus and bone marrow. Such lymphocytes were not detectable at all in control mice. Some ofthe actual profiles are shown in Fig. 2 B. Liver MNC consisted of both CD3*4 -$ -DN lymphocytes and CD3 * 4 * (or 8 * ) lymphocytes, whereas MNC of the lymph nodes consisted mainly of CD3*4 -8 -DN lymphocytes. We then analyzed the phenotype of in vitro proliferating liver MNC in MRL/lpr mice (Fig. 2 C) . As we observed that liver MNC depleted of CD3 * cells by complement-mediated cell lysis using anti-CD3 antibody still had the ability to proliferate in vitro, the phenotype of liver MNC depleted of CD3' cells was examined before and after a 3-d culturing. The liver MNC depleted of CD3 * cells initially lacked the CD3, CD4, CD8, and TCR-a/0 antigens (<4%) . After the culture, the prominently increased expression of CD3 and TCRa/(3 antigens (up to 14%), but not of CD4 and CD8 antigens (see the bottom of Fig. 2 C) , was demonstrated . Here, the actual increase of the cell number was -1 . TdR incorporation as well, whereas that of the thymus was at the basal level during the entire period tested. Of particular interest was that MNC in the lymph nodes showed a peak of radioactivity on day 5. As significant radioactivity was not detected in the serum on days 4 and 5 (Fig. 3, dotted Cytotoxicity ofLiverMNC. It has been previously demonstrated that liver MNC in MRL/Ipr mice have potent rytotoxic activity against tumor target cells (13). We further examined whether such high rytotoxic activity was confined to liver MNC . The rytotoxic function against YAC-1 tumor cells was examined by a specific "Cr-release assay of a 4-h analysis . The increased rytotoxicity was restricted to the liver MNC in MRL/lpr mice ( Table 2 ). The complement-mediated cytolysis by using anti-asialo GMt and anti-CD3 antibodies revealed that not only asialo GM) * NK cells but also CD3+4 -8 -cells mediated rytotoxicity against the NK-resistant target (data not shown) .
Discussion
In the present study, we demonstrated that the number of liver MNC in the diseased MRL/Ipr mice was 10 times greater than that of control MRL/+ mice. Moreover, the isolated liver MNC of MRL/lpr mice vigorously proliferate in vitro and:-consisted of abnormal CD3*4 -8 -DN lymphocytes:. In a morphological study, we also observed that >70% of MNC -in the hepatic sinusoid were lymphoblastic in MRL/lpr mice, whereas almost all MNC (>95%) in the lymph nodes were small resting lymphocytes (Masuda et al., manuscript in preparation) . It is, therefore, presumed that liver MNC, including abnormal DN lymphocytes, are in an TdR injection experiments suggest that hepatic DN lymphocytes may be a source of abnormal lymphocytes constituting the lymphadenopathy of lymph nodes . We previously established that MNC could be isolated from liver of mice after perfusion with PBS from the portal vein, in conjunction with Ficoll-Isopaque gradient centrifugation (12) . The isolated MNC mainly consisted of T lymphocytes and NK cells, but only a small proportion of Kupffer cells (<4%) . When we estimated the number of hepatic MNC in a small aliquot of the mixed cell suspection (i.e., the mixture of hepatocytes and hepatic MNC) before the application of gradient centrifugation, the number of hepatic MNC was approximately five times greater than that of hepatic MNC after application of gradient centrifugation . Such a cell yield was not variable between MRL/Ipr and MRL/+ mice . As the cell yield of liver MNC isolated by the present method was X20%, the actual cell number of liver MNC in the diseased MRL/Ipr mice was -4 x 10' cells/liver. This number dinate is indicated by green (fluorescein) and the abscissa is indicated by red (phycoerythrin) . Complement-mediated cell lysis was applied to eliminate CD3', CD4', or CD8' cells in conjunction with unconjugated aliquots of the anti-CD3, CD4 (L3T4), and CD8 (Lyt-2) antibodies (murine IgM or IgG2b), which are complement-fixing reagents . Here, the anti-CD3 antibody was murine IgM and was not mitogenic for T lymphocytes. is almost comparable with that of the spleen in normal young adult mice feeding under pathogen-free conditions. On the other hand, the number of liver MNC (ti4 x 106 cells/ liver) in MRL/+ mice was comparable with those of other strains of mice, as shown in our previous study (12) .
In the in vitro culture system, we observed that liver MNC depleted of CD3+ cells still had the ability to proliferate, and that the prominent increased expression of CD3 and TCRcx/(3 antigens, but not ofCD4 and CD8 antigens, was demonstrated . TCRcx//3+CD3+4 -8 -cells, therefore, might expand from either null cell precursors or a minor remaining population of TCR-cx/(3+CD3+4 -8 -cells . On the other hand, we could not induce in vitro such TCR-ct/a+CD3+4 -8 -cells from bone marrow cells in MRL/Ipr mice. It is conceivable that, even if the earliest precursors ofabnormal lymphocytes themselves come from the bone marrow (14) , such lymphocytes may have to encounter hepatic microenvironments for maximum expansion .
There are several reports that neonatal thymectomy significantly reduces the lymphadenopathy and autoimmunity in MRL/Ipr mice (15) (16) (17) . However, there is no evidence that abnormal lymphocytes proliferate in the thymus based on the 11 Ohteki et al.
results of the present in vitro and in vivo studies. Therefore, two possibilities can be proposed to explain this phenomenon. The first possibility is that the precursor cells of abnormal lymphocytes in the bone marrow of MRL/Ipr mice pass through the thymus and proliferate in the liver. Even in this case, the thymus may not be a major site for the expansion of these cells. The second possibility is that abnormal lymphocytes in the liver may directly come from the bone marrow and be generated by entirely extrathymic proliferation. Thus, the liver MNC depleted of CD3+ cells in MRL/lpr mice are still able to proliferate in vitro and produce CD3+4 -8 -DN lymphocytes. In this case, as abnormal TCR-ct/0+ DN lymphocytes are generated in the liver, it is easy to consider that such cells may be autoreactive due to the escape from thymic education. In recent studies, the possibility of extrathymic maturation of TCR-ct/R+ and TCR , y /S+ cells has been shown. (18) (19) (20) . There is also an earlier report that the transplantation of the thymus from a normal mouse to a thymectomized MRL/Ipr mouse did not prevent lymphadenopathy and autoimmunity (16) . This experimental result also seems to support the second possibility. In this case, we prefer to consider the possibility that normal CD4+ (and/or CD8+) cells, which come from the thymus and are abundant in the liver of MRL/Ipr mice (Fig. 2, A and B) , may support the growth of abnormal lymphocytes in the liver, since the percentages of normal CD4+ and CD8+ cells existing in the liver, spleen, and lymph nodes correlate well with the proliferation activity of CD3+4 -8 -cells in these organs . This conception is supported by several reports that anti-CD4 antibody treatment in vivo reduced the onset of autoimmunity in MRL/Ipr mice (21, 22) .
We have recently demonstrated that liver MNC, in not only aged MRL/+ mice (>40 wk of age), but also in other autoimmune mice such as BXSB and NZB/W Fl strains, are characterized by increased cell proliferation activity accompanying the increased number of liver MNC (Ohteki et al., unpublished observation) . This evidence suggests that the liver may be the most important site for proliferation of abnormal autoreactive lymphocytes in mice with a wide range of autoimmune diseases. However, the above autoimmune mice do not show prominent lymphadenopathy in the peripheral lymphoid organs. It is, therefore, conceivable that MRL/Ipr mice have an additional feature, such as the accumulation of abnormal lymphocytes in the peripheral lymphoid organs, probably due to the homing abnormality of such lymphocytes, that may be responsible for the acceleration of their autoimmunity (10) . As increased TCR cx/a+ DN cells were also demonstrated in the patients with SLE (7), whether such lymphocytes also proliferate in the liver of patients with autoimmune diseases is under investigation .
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